Nifty

:

25571.25

Sensex

:

82814.71

116.90 (0.46%)
316.57 (0.38%)

Login

Nifty
Sensex

:
:

25571.25
82814.71

116.90 (0.46%)
316.57 (0.38%)

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

72/99

BSE: 539730 | NSE: Not Listed

Watchlist

NSE BSE

1664.20

20-Feb-2026

Open
High
Low
Previous Close

1714
1750
1601
1712.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

8457
14029444
1750
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

893.01
27.33
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,056.08
0.04%
3.60

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

26.78
27.65
18.22

EBITDA CAGR (%)

10 Years
5 Years
3 Years

29.73
41.32
13.64

PAT CAGR (%)

10 Years
5 Years
3 Years

34.55
59.59
24.40

P:E (Median)

8 Years
5 Years
3 Years

38.03
34.14
26.62

P:BV (Average)

8 Years
5 Years
3 Years

3.96
4.27
3.51

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.66
18.55
12.85

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 160.92 102.70 56.69% 145.29 107.35 35.34% 119.85 78.81 52.07% 167.41 118.03 41.84%
Expenses 134.59 89.47 50.43% 122.96 93.40 31.65% 102.86 68.33 50.53% 149.97 106.87 40.33%
EBITDA 26.33 13.23 99.02% 22.33 13.95 60.07% 16.99 10.48 62.12% 17.44 11.17 56.13%
EBIDTM 16.36% 12.88% 15.37% 13.00% 14.18% 13.30% 10.42% 9.46%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 10.55 5.00 111.00% 7.73 5.31 45.57% 6.53 3.91 67.01% 8.15 4.37 86.50%
Depreciation 1.78 1.09 63.30% 1.60 1.06 50.94% 1.42 1.05 35.24% 1.25 0.96 30.21%
PBT 14.00 7.13 96.35% 13.01 7.58 71.64% 9.04 5.52 63.77% 8.04 5.84 37.67%
Tax 3.52 1.80 95.56% 3.27 3.30 -0.91% 2.27 1.39 63.31% 0.97 0.78 24.36%
PAT 10.48 5.33 96.62% 9.73 4.27 127.87% 6.77 4.13 63.92% 7.07 5.06 39.72%
PATM 6.51% 5.19% 6.70% 3.98% 5.64% 5.24% 4.22% 4.29%
EPS 19.40 9.88 96.36% 18.02 7.91 127.81% 12.53 7.65 63.79% 13.10 9.38 39.66%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 160.92 0.00 0 145.29 0.00 0 119.85 0.00 0 167.41 0.00 0
Expenses 134.59 0.00 0 122.96 0.00 0 102.86 0.00 0 150.16 0.00 0
EBITDA 26.33 0.00 0 22.33 0.00 0 16.99 0.00 0 17.25 0.00 0
EBIDTM 16.36% 0.00% 15.37% 0.00% 14.18% 0.00% 10.30% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 10.55 0.00 0 7.73 0.00 0 6.53 0.00 0 8.15 0.00 0
Depreciation 1.78 0.00 0 1.89 0.00 0 1.42 0.00 0 1.84 0.00 0
PBT 14.00 0.00 0 12.71 0.00 0 9.04 0.00 0 7.26 0.00 0
Tax 3.52 0.00 0 3.27 0.00 0 2.27 0.00 0 1.26 0.00 0
PAT 10.48 0.00 0 9.43 0.00 0 6.77 0.00 0 6.00 0.00 0
PATM 6.51% 0.00% 6.49% 0.00% 5.64% 0.00% 3.59% 0.00%
EPS 19.53 0.00 0 19.97 0.00 0 14.33 0.00 0 12.71 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 593.47 453.82 348.16 274.68 224.46 133.89 112.77 97.02 59.55 56.70 42.32 Net Sales Growth 45.86% 30.35% 26.75% 22.37% 67.65% 18.73% 16.23% 62.92% 5.03% 33.98% Cost Of Goods Sold 424.60 330.03 261.32 208.68 177.10 102.25 81.75 59.88 39.51 24.57 19.04 Gross Profit 168.87 123.79 86.83 65.99 47.35 31.65 31.02 37.14 20.04 32.12 23.29 GP Margin 28.45% 27.28% 24.94% 24.02% 21.10% 23.64% 27.51% 38.28% 33.65% 56.65% 55.03% Total Expenditure 510.38 401.17 310.17 246.90 210.55 124.55 104.44 86.99 53.84 53.37 38.42 Power & Fuel Cost - 5.45 4.47 3.37 3.49 2.94 3.10 2.75 1.60 1.64 1.17 % Of Sales - 1.20% 1.28% 1.23% 1.55% 2.20% 2.75% 2.83% 2.69% 2.89% 2.76% Employee Cost - 22.23 12.50 11.54 10.66 8.66 8.95 8.04 5.19 4.92 3.83 % Of Sales - 4.90% 3.59% 4.20% 4.75% 6.47% 7.94% 8.29% 8.72% 8.68% 9.05% Manufacturing Exp. - 15.25 10.34 7.24 4.41 3.13 3.58 4.03 1.21 15.32 9.47 % Of Sales - 3.36% 2.97% 2.64% 1.96% 2.34% 3.17% 4.15% 2.03% 27.02% 22.38% General & Admin Exp. - 21.50 15.85 10.81 8.72 5.47 5.19 7.13 3.57 3.34 1.93 % Of Sales - 4.74% 4.55% 3.94% 3.88% 4.09% 4.60% 7.35% 5.99% 5.89% 4.56% Selling & Distn. Exp. - 5.22 5.07 4.24 5.61 1.77 1.76 2.59 2.54 3.46 2.71 % Of Sales - 1.15% 1.46% 1.54% 2.50% 1.32% 1.56% 2.67% 4.27% 6.10% 6.40% Miscellaneous Exp. - 1.50 0.62 1.00 0.56 0.33 0.11 2.57 0.21 0.11 2.71 % Of Sales - 0.33% 0.18% 0.36% 0.25% 0.25% 0.10% 2.65% 0.35% 0.19% 0.64% EBITDA 83.09 52.65 37.99 27.78 13.91 9.34 8.33 10.03 5.71 3.33 3.90 EBITDA Margin 14.00% 11.60% 10.91% 10.11% 6.20% 6.98% 7.39% 10.34% 9.59% 5.87% 9.22% Other Income 0.00 2.45 0.92 1.82 1.63 1.40 0.52 0.58 0.16 1.91 0.86 Interest 32.96 22.38 13.65 9.28 4.78 4.37 4.47 3.12 1.95 1.87 2.06 Depreciation 6.05 4.45 3.80 2.81 2.16 2.00 1.88 1.33 1.29 1.14 0.80 PBT 44.09 28.27 21.45 17.51 8.60 4.37 2.49 6.16 2.64 2.23 1.90 Tax 10.03 7.46 5.83 6.70 2.26 1.19 0.59 1.70 0.89 0.80 0.77 Tax Rate 22.75% 26.39% 27.18% 38.26% 26.28% 37.07% 23.69% 27.60% 33.71% 35.87% 41.85% PAT 34.05 20.81 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 1.07 PAT before Minority Interest 34.05 20.81 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 1.07 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.74% 4.59% 4.49% 3.94% 2.82% 1.50% 1.68% 4.60% 2.94% 2.52% 2.53% PAT Growth 81.21% 33.23% 44.50% 70.50% 215.42% 5.79% -57.40% 154.86% 22.38% 33.64% EPS 63.06 38.54 28.93 20.02 11.74 3.72 3.52 8.26 3.24 2.65 1.98

Description TTM Mar 25
Net Sales - 453.82 Net Sales Growth - Cost Of Goods Sold - 330.03 Gross Profit - 123.79 GP Margin - 27.28% Total Expenditure - 401.36 Power & Fuel Cost - 5.45 % Of Sales - 1.20% Employee Cost - 22.23 % Of Sales - 4.90% Manufacturing Exp. - 15.25 % Of Sales - 3.36% General & Admin Exp. - 21.36 % Of Sales - 4.71% Selling & Distn. Exp. - 5.43 % Of Sales - 1.20% Miscellaneous Exp. - 1.61 % Of Sales - 0.35% EBITDA - 52.46 EBITDA Margin - 11.56% Other Income - 2.45 Interest - 22.38 Depreciation - 5.04 PBT - 27.49 Tax - 7.75 Tax Rate - 28.19% PAT - 19.74 PAT before Minority Interest - 19.74 Minority Interest - 0.00 PAT Margin - 4.35% PAT Growth - EPS - 36.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 141.40 121.47 96.38 68.06 43.07 41.32 38.99 22.16 7.26 3.96 Share Capital 4.72 4.70 4.53 4.43 3.99 3.99 3.99 3.43 4.87 2.62 Total Reserves 136.68 115.20 83.52 63.42 39.08 37.33 35.00 18.74 2.39 1.34 Non-Current Liabilities 17.93 19.30 21.25 45.18 32.09 14.07 12.51 4.06 8.37 7.31 Secured Loans 9.61 12.80 15.44 42.04 29.11 11.50 10.64 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.24 6.19 Long Term Provisions 3.83 2.37 1.96 1.71 1.60 1.63 1.08 3.25 0.28 0.43 Current Liabilities 327.32 166.83 139.66 73.75 86.46 85.99 53.41 53.04 40.47 31.93 Trade Payables 144.76 62.95 59.34 48.62 59.96 46.22 33.70 38.92 22.83 16.27 Other Current Liabilities 25.57 11.59 8.31 11.62 14.84 13.79 8.94 1.33 7.75 7.18 Short Term Borrowings 149.87 86.76 67.71 10.72 10.53 23.41 8.63 9.90 7.58 6.85 Short Term Provisions 7.12 5.54 4.29 2.79 1.13 2.57 2.13 2.89 2.31 1.62 Total Liabilities 486.65 307.60 257.29 186.99 161.62 141.38 104.91 79.26 56.10 43.20 Net Block 52.57 46.57 38.93 32.34 30.35 30.97 31.35 16.28 20.50 14.51 Gross Block 79.70 69.26 51.54 42.14 37.99 36.61 35.11 25.00 27.93 20.80 Accumulated Depreciation 27.14 22.69 12.61 9.80 7.64 5.64 3.76 8.71 7.43 6.29 Non Current Assets 59.12 50.46 41.07 34.34 31.54 32.05 32.39 27.78 20.85 14.92 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.15 0.00 0.00 Non Current Investment 0.76 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 5.30 3.36 2.13 2.00 1.18 1.08 1.03 0.35 0.35 0.31 Other Non Current Assets 0.49 0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 Current Assets 427.53 257.14 216.21 152.65 130.08 109.32 72.52 51.48 35.24 28.28 Current Investments 0.75 0.75 0.31 0.06 0.06 0.05 0.00 0.00 0.00 0.00 Inventories 239.89 175.00 150.12 46.46 67.57 50.46 40.78 18.43 6.94 10.27 Sundry Debtors 177.12 64.85 34.56 90.27 41.08 38.97 17.78 15.26 20.38 11.40 Cash & Bank 4.82 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 Other Current Assets 4.96 1.44 0.75 0.58 20.25 16.78 12.49 16.35 7.18 5.22 Short Term Loans & Adv. 1.82 13.76 27.03 13.20 19.89 16.49 0.75 7.70 6.31 5.01 Net Current Assets 100.21 90.31 76.55 78.90 43.63 23.33 19.11 -1.56 -5.23 -3.65 Total Assets 486.65 307.60 257.28 186.99 161.62 141.37 104.91 79.26 56.09 43.20

Description Mar 25
Shareholder's Funds 141.38 Share Capital 4.72 Total Reserves 136.66 Non-Current Liabilities 17.93 Secured Loans 9.61 Unsecured Loans 0.00 Long Term Provisions 3.83 Current Liabilities 328.10 Trade Payables 144.77 Other Current Liabilities 25.60 Short Term Borrowings 150.61 Short Term Provisions 7.12 Total Liabilities 487.41 Net Block 52.92 Gross Block 80.65 Accumulated Depreciation 27.73 Non Current Assets 59.46 Capital Work in Progress 0.00 Non Current Investment 0.75 Long Term Loans & Adv. 5.30 Other Non Current Assets 0.49 Current Assets 427.95 Current Investments 0.75 Inventories 239.89 Sundry Debtors 177.12 Cash & Bank 5.22 Other Current Assets 4.97 Short Term Loans & Adv. 1.83 Net Current Assets 99.86 Total Assets 487.41

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -28.88 -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 3.33 PBT 28.27 21.45 17.46 8.58 2.01 2.35 6.18 1.75 2.23 1.83 Adjustment 27.00 16.77 11.70 7.82 8.65 6.03 2.08 2.67 2.00 1.74 Changes in Working Capital -84.16 -38.66 -43.57 -18.77 -10.50 -19.02 -7.43 12.88 -0.25 -0.25 Cash after chg. in Working capital -28.88 -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 3.33 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.99 -7.64 -9.40 -4.14 -1.39 -1.49 -5.25 -8.21 -7.13 -5.99 Net Fixed Assets -10.44 -17.72 -9.40 -4.15 -1.38 -1.50 1.04 -8.22 -7.13 -5.99 Net Investments -0.70 -0.50 -0.25 0.00 -0.01 -0.05 0.00 0.00 0.00 0.00 Others 5.15 10.58 0.25 0.01 0.00 0.06 -6.29 0.01 0.00 0.00 Cash from Financing Activity 38.34 5.99 25.18 7.47 -0.71 13.73 4.43 -8.38 2.52 3.45 Net Cash Inflow / Outflow 3.47 -2.08 1.36 0.94 -1.93 1.59 0.01 0.70 -0.64 0.79 Opening Cash & Equivalents 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60 Closing Cash & Equivalent 4.82 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39

Description Mar 25
Cash From Operating Activity -29.06 PBT 27.49 Adjustment 27.59 Changes in Working Capital -84.15 Cash after chg. in Working capital -29.06 Interest Paid 0.00 Tax Paid 0.00 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -6.35 Net Fixed Assets Net Investments Others Cash from Financing Activity 39.12 Net Cash Inflow / Outflow 3.70 Opening Cash & Equivalents 1.52 Closing Cash & Equivalent 5.22

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 299.47 255.15 194.27 153.07 107.96 103.57 97.73 64.71 20.14 15.68 ROA 5.24% 5.53% 4.86% 3.63% 1.33% 1.54% 4.84% 2.59% 2.88% 3.23% ROE 15.93% 15.03% 13.86% 11.42% 4.77% 4.74% 14.59% 13.02% 33.88% 33.46% ROCE 18.94% 17.13% 17.64% 13.15% 9.53% 10.36% 20.56% 15.90% 18.16% 24.67% Fixed Asset Turnover 6.09 5.76 5.86 5.60 3.59 3.14 3.23 2.25 2.33 2.47 Receivable days 97.31 52.11 82.94 106.79 109.11 91.85 62.16 109.23 102.30 71.54 Inventory Days 166.84 170.43 130.61 92.72 160.89 147.66 111.37 77.73 55.39 62.77 Payable days 114.86 85.40 94.41 111.88 189.53 178.44 158.25 217.97 146.17 106.16 Cash Conversion Cycle 149.29 137.13 119.14 87.63 80.47 61.07 15.28 -31.02 11.52 28.15 Total Debt/Equity 1.18 0.88 0.98 0.78 0.92 0.84 0.49 0.45 2.53 3.92 Interest Cover 2.26 2.57 2.89 2.80 1.73 1.56 2.97 2.36 2.19 1.89

Description Mar 25
Book Value (Rs.) 299.43 ROA 4.05% ROE 13.96% ROCE 16.16% Fixed Asset Turnover 5.63 Receivable days 142.46 Inventory Days 192.94 Payable days 160.10 Cash Conversion Cycle 175.29 Total Debt/Equity 1.18 Interest Cover 2.23

Top Investors:

nikhil kishorchandra vora

arun kumar mukherjee

harsha venkatesh

Annual Reports:

News Update:

Fredun Pharma - Quarterly Results
10th Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback